Gene Weaver
Developer of a naturally derived, programmable enzymatic platform for controlled cutting and precision insertion of large genetic payloads. Focus areas include engineering specificity and programmability of recognition elements, enabling large-fragment DNA insertion and methods intended for use in mammalian cells. Cambridge-based, founded mid-2023.
Industries
Nr. of Employees
small (1-50)
Gene Weaver
Cambridge, Cambridgeshire, United Kingdom, Europe
Products
Programmable gene insertion platform (naturally derived enzymatic system)
A platform based on a naturally occurring enzymatic system engineered for programmable recognition, controlled cutting, and precision insertion of large genetic payloads.
Programmable gene insertion platform (naturally derived enzymatic system)
A platform based on a naturally occurring enzymatic system engineered for programmable recognition, controlled cutting, and precision insertion of large genetic payloads.
Services
Collaborative development and licensing for delivery integration
Partnership-based collaborations to integrate intracellular delivery methods with programmable gene insertion technology, including development of optimized delivery workflows.
Collaborative development and licensing for delivery integration
Partnership-based collaborations to integrate intracellular delivery methods with programmable gene insertion technology, including development of optimized delivery workflows.
Expertise Areas
- Programmable gene insertion
- Enzymatic gene editing
- Large-fragment DNA insertion
- Assay development for nucleic acid recombination
Key Technologies
- Programmable enzymatic insertion platform
- Large-fragment DNA insertion
- Non-DSB insertion methods
- In vitro recombination assays